Yu Chen-Ming
Insider CIK 1517933 · SGNT Interim COO, Director · SRZN 10% owner · TCGX Chief Executive Officer, 10% owner · TCXB Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TCXB TCGX Acquisition Corp. II | A Award | 2026-10-19 | 2026-10-20 | 450,000 | $10.00 | $4.50M | 450,000 | SEC↗ |
| TCGX TCGX Acquisition Corp. | A Award | 2026-08-06 | 2026-08-06 | 436,250 | $10.00 | $4.36M | 436,250 | SEC↗ |
| TCGX TCGX Acquisition Corp. | A Award | 2026-08-06 | 2026-08-06 | 436,250 | $10.00 | $4.36M | 436,250 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale | 2026-07-22 | 2026-07-24 | 162,500 | $21.25 | $3.45M | 574,047 | SEC↗ |
| SRZN Surrozen, Inc./DE | S Sale | 2026-07-22 | 2026-07-24 | 162,500 | $21.25 | $3.45M | 574,054 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2012-09-07 | 2012-09-11 | 105,000 | — | $0 | 105,000 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2012-02-22 | 2012-02-24 | 2,268 | — | $0 | 2,268 | SEC↗ |